Overview and Scope
A comprehensive metabolic panel (CMP) test is a blood test containing 14 separate parameters that offer crucial knowledge about the body’s chemical equilibrium and metabolism. It is frequently used to assess nutritional levels, liver and kidney function, and diagnosis, screening, and monitoring.
Sizing and Forecast
The comprehensive metabolic panel (cmp) testing market size has grown strongly in recent years. It will grow from $15.61 billion in 2023 to $16.94 billion in 2024 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to rise in chronic diseases, demand for holistic health assessments, healthcare system emphasis on preventive care, rise in lifestyle-related conditions, patient-centric healthcare approach.
The comprehensive metabolic panel (cmp) testing market size is expected to see strong growth in the next few years. It will grow to $23.28 billion in 2028 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to personalized medicine and precision healthcare, integration of cmp testing in telehealth services, demand for comprehensive health screenings, rise in wellness and preventive health initiatives, evolving healthcare policies and regulations. Major trends in the forecast period include continuous monitoring and longitudinal tracking, telemedicine-friendly reporting formats, standardization of reference ranges, integration of wearable health technology, emphasis on patient education and engagement.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/comprehensive-metabolic-panel-cmp-testing-global-market-report
Segmentation & Regional Insights
The comprehensive metabolic panel (cmp) testing market covered in this report is segmented –
1) By Disease: Kidney Disease, Liver Disease, Diabetes, Other Diseases
2) By Test Type: Proteins, Electrolytes, Kidney Tests, Liver Functional Tests, Glucose
3) By End User: Laboratories, Point Of Care (PoC)
North America was the largest region in the comprehensive metabolic panel (CMP) testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the comprehensive metabolic panel (cmp) testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12362&type=smp
Major Driver Impacting Market Growth
The increasing prevalence of cardiovascular diseases and diabetes is expected to propel the growth of the comprehensive metabolic panel (CMP) testing market going forward. Cardiovascular disorders affect the heart or blood vessels and are linked to atherosclerosis, the build-up of fatty deposits inside the arteries. Diabetes is a condition that develops when blood glucose levels are too high. Comprehensive metabolic panel (CMP) blood tests detect glucose levels. Thus, with the increasing cases of diabetes and cardiovascular diseases, the need for their diagnosis through blood tests such as the CMP blood test will support the market’s growth. For instance, in December 2023, according to the Australian Institute of Health and Welfare, an Australia-based national agency that oversees public health and wellness, there were 13,700 doctor-certified fatalities attributable to CHD in 2020, increasing to 14,100 in 2021 and 14,900 in 2022. Furthermore, in June 2022, according to the International Diabetes Federation, a Belgium-based diabetes federation, the prevalence of diabetes had increased to 10.5% worldwide, with over half (44.7%) of people still undiagnosed. Therefore, the increasing prevalence of cardiovascular diseases and diabetes is driving the growth of the comprehensive metabolic panel (CMP) testing market.
Key Industry Players
Major companies operating in the comprehensive metabolic panel (cmp) testing market report are F Hoffmann-La Roche Ltd., Abbott Laboratories Inc., Siemens Healthineers AG, Mayo Clinic, Laboratory Corporation of America Holdings, Mercy, Mount Sinai Health System, Quest Diagnostics Incorporated, Sonic Healthcare Limited, Hologic Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., Werfen SA, DiaSorin S.p.A., Randox Laboratories Ltd., ARUP Laboratories Inc., Invitae Corporation, Abaxis Inc., Metropolis Healthcare Limited, Clinical Reference Laboratory (CRL), Centogene AG, Spectra Laboratories, Unipath Systems Ltd., Scion Lab Services LLC, Weldon Biotech Pvt Ltd., Corona Pathology,Ulta Lab Tests LLC, Any Lab Test Now, Applied InGENuity Diagnostics LLC, Walk-In Lab LLC.
The comprehensive metabolic panel (cmp) testing market report table of contents includes:
1. Executive Summary
2. Comprehensive Metabolic Panel (CMP) Testing Market Characteristics
3. Comprehensive Metabolic Panel (CMP) Testing Market Trends And Strategies
4. Comprehensive Metabolic Panel (CMP) Testing Market – Macro Economic Scenario
5. Global Comprehensive Metabolic Panel (CMP) Testing Market Size and Growth
.
.
.
32. Global Comprehensive Metabolic Panel (CMP) Testing Market Competitive Benchmarking
33. Global Comprehensive Metabolic Panel (CMP) Testing Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Comprehensive Metabolic Panel (CMP) Testing Market
35. Comprehensive Metabolic Panel (CMP) Testing Market Future Outlook and Potential Analysis
36. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
